Clinical Trials on Human Papilloma Virus in Singapore

Total 187 results

National University Hospital, Singapore
Sanofi Pasteur, a Sanofi Company; National University, Singapore; Agency for...

Completed

The Immune Response to Influenza Vaccinations in Elderly Individuals

Influenza

Singapore
Tan Tock Seng Hospital
National Healthcare Group, Singapore

Completed

Tropical Influenza Control Strategies for the Elderly (TROPICS1)

Influenza, Human

Singapore
National University Hospital, Singapore

Unknown

The Chloroquine for Influenza Prevention Trial (CHIP)

Influenza

Singapore
Tan Tock Seng Hospital
Sanofi; A*Star; World Health Organization Collaborating Centre for Reference...

Recruiting

Immunogenicity Trial of 3 Influenza Vaccines

Influenza Vaccination

Singapore
Tan Tock Seng Hospital
Frontier Healthcare Group; OneCare Medical Group

Completed

Increasing the Uptake of Influenza and Pneumococcal Vaccines Among High-Risk Adult Patients Through GP Clinics

Immunization Programs

Singapore
National University Hospital, Singapore

Unknown

Antigen-specific Immune Response to Hepatitis B Virus in Utero

Hepatitis B

Singapore
Changi General Hospital

Completed

Prevalence of IL28B Polymorphism in Hepatitis C Patients

Hepatitis C

Singapore
Ology Bioservices

Completed

Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Influenza

Singapore, Austria
Changi General Hospital
National University Hospital, Singapore; Merck Sharp & Dohme LLC

Completed

Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers

Human Immunodeficiency Virus

Singapore
F-star Therapeutics, Inc.
CSI Medical Research Pte Ltd

Terminated

Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients

Hepatitis B | Hepatitis B, Chronic | HBV

Singapore
ViiV Healthcare
Pfizer

Completed

Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers

Human Immunodeficiency Virus (HIV) Infection

Singapore
Seng Gee Lim
Singapore General Hospital; Tan Tock Seng Hospital; Changi General Hospital

Unknown

Halting Nucleoside Analogues in Chronic Hepatitis B (HALT-NUCS)

Chronic Hepatitis B

Singapore
Seng Gee Lim
National Medical Research Council (NMRC), Singapore; Singapore Clinical Research...

Unknown

Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B (DUAL)

Chronic Hepatitis B

Singapore
Seng Gee Lim
Roche Pharma AG

Unknown

Peg-interferon for Inactive Chronic Hepatitis B Carriers (INACTIVE)

Chronic Hepatitis, B Virus | Carrier of Viral Hepatitis Type B

Singapore
Ology Bioservices

Completed

Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Influenza

Singapore, Hong Kong
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months

Influenza

Singapore
Seng Gee Lim
Merck Sharp & Dohme LLC; Singapore General Hospital; Tan Tock Seng Hospital; Changi... and other collaborators

Completed

Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy (SWAP)

Chronic Hepatitis B

Singapore
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Chronic Hepatitis B

Singapore
Changi General Hospital
National University Hospital, Singapore

Completed

Epidemiology of Chronic Hepatitis C and Disease Modelling (EPIC)

Hepatitis C

Singapore
Pfizer

Completed

Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin Pharmacokinetics

Human Volunteers

Singapore
GlaxoSmithKline

Completed

Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules

Influenza

Taiwan, Hong Kong, Thailand, Singapore
GlaxoSmithKline

Completed

Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults

Influenza | Influenza Vaccines

Taiwan, Hong Kong, Thailand, Singapore
Singapore General Hospital

Completed

Using GM-CSF as a Host Directed Therapeutic Against COVID-19

COVID | ARDS, Human | Sars-CoV2

Singapore
Tan Tock Seng Hospital
National Healthcare Group, Singapore; Singapore Immunology Network

Unknown

Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial

Diabetes Mellitus | Immune Response | Vitamin D Deficiency | Elderly | Influenza Vaccine | Metabolic Disease

Singapore
Novartis
Novartis Pharmaceuticals

Completed

Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

Hepatitis B

Hong Kong, Singapore, New Zealand
National Institute of Allergy and Infectious Diseases...
University of Oxford; Wellcome Trust; World Health Organization

Completed

High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

Influenza | Avian Influenza | Severe Influenza

Singapore, Thailand, Vietnam
Mina Alpha Limited

Active, not recruiting

Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone (OUTREACH2)

Hepatitis B | Hepatocellular Carcinoma | Hepatitis C

Singapore, United States
SCG Cell Therapy Pte. Ltd.

Recruiting

A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma (TCR-T)

Hepatocellular Carcinoma Recurrent | Hepatitis B Virus Related Hepatocellular Carcinoma

United States, Singapore, Hong Kong
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Influenza

Australia, Singapore
National University Hospital, Singapore

Unknown

Expression of S100A2 and Trefoil Factor Family Members in Epstein-Barr Virus Related Gastric Cancer

Gastric Cancer

Singapore
Tychan Pte Ltd.
Duke-NUS Graduate Medical School; Singapore Clinical Research Institute

Withdrawn

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients

Treatment of Acute Zika Virus Infection

Singapore
Tychan Pte Ltd.
National University Hospital, Singapore; National University, Singapore; Duke-NUS... and other collaborators

Completed

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans

Treatment of Acute Zika Virus Infection

Singapore
Janssen Research & Development, LLC

Terminated

A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection

Hepatitis C

Singapore, Canada, Poland, New Zealand
National Cancer Centre, Singapore
National Cancer Centre Research Fund

Recruiting

Somatostatin Receptor Imaging in NPC, EBV Related Cancers

Nasopharyngeal Cancer | Epstein-Barr Virus Related Carcinoma

Singapore
GlaxoSmithKline

Completed

A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

Infections, Rotavirus

Singapore
Hoffmann-La Roche

Completed

A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both

Hepatitis B, Chronic

Taiwan, United States, New Zealand, Singapore
Hoffmann-La Roche

Completed

A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies

Hepatitis B, Chronic

Taiwan, United States, New Zealand, Singapore
Triangle Pharmaceuticals

Unknown

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Hepatitis B

United States, Canada, China, France, Singapore
Yisheng Biopharma (Singapore) Pte. Ltd.

Completed

Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen

Rabies

Singapore
National University Hospital, Singapore

Unknown

Efficacy Trial of Eutectic Lidocaine/Prilocaine Cream 5% (EMLA) for Analgesia Prior to Cryotherapy of Verrucae Plantaris

Plantar Warts

Singapore
Yisheng Biopharma (Singapore) Pte. Ltd.
Duke-NUS Graduate Medical School

Completed

Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant

Rabies

Singapore
GlaxoSmithKline

Completed

Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)

Infections, Rotavirus

Singapore
Tysana Pte Ltd

Completed

Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans

Treatment of Acute Yellow Fever Virus Infection

Singapore
Yale-NUS College

Completed

Characteristics of TraceTogether Users

Coronavirus

Singapore
Ology Bioservices

Completed

Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents

Influenza, Avian

Australia, Finland, Singapore, Spain
Yale-NUS College

Completed

Migrant Workers' Responses to the COVID-19 Pandemic

Coronavirus | Trust | Misinformation

Singapore
PowderMed

Completed

Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection

Chronic Hepatitis B

Thailand, Hong Kong, Singapore, Taiwan
Janssen Research & Development, LLC

Terminated

A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever

Dengue

Singapore
National Environment Agency, Singapore
Ministry of Health, Singapore

Recruiting

Impact of Project Wolbachia - Singapore on Dengue Incidence

Dengue

Singapore
SingHealth Polyclinics

Completed

Effects of a Serious Game on Knowledge, Attitude and Practice in Vector Control and Dengue Prevention Among Adults in Primary Care

Dengue

Singapore

Clinical Trials on Human Papilloma Virus in Singapore

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations